George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

Oxford Biodyn Share News (OBD)

Oxford Biodyn Information

Buy OBD Shares
Add OBD to Watchlist
Add OBD to Alert

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange

Share Price is delayed by 15 minutes

Share Price: 8.10

Bid: 8.10

Ask: 8.48

Change: -0.10 (-1.22%)

Spread: 0.38 (4.691%)

Open: 8.00

High: 8.50

Low: 8.00

Prev. Close: 8.20

OBD Live Price

Last checked at -

IN BRIEF: Oxford BioDynamics Covid severity tests available in US

Fri, 17th Dec 2021 20:34

Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic biomarkers - Says its EpiSwitch Covid-19 severity test is available in the US and that it has seen increased interest following the resurgence of the Delta and Omicron variants. Says EpiSwitch can identify those with the greatest risk of experiencing critical, life-threatening disease because of a SARS-Cov-2 viral infection. Oxford BioDynamics expects to launch blood-based predictive tests in early 2022.

Current stock price: 34.00 pence

Year-to-date change: down 59%

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News

16 Mar 2020 16:14

EXECUTIVE CHANGE SUMMARY: Globalworth Founder To Focus On Exec Role

EXECUTIVE CHANGE SUMMARY: Globalworth Founder To Focus On Exec Role

2 Mar 2020 19:43

CORRECT: Oxford BioDynamics Director Diggle Buys Shares

CORRECT: Oxford BioDynamics Director Diggle Buys Shares

26 Feb 2020 15:20

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

15 Jan 2020 15:17

Oxford BioDynamics Demonstrates Use Of EpiSwitch In Lymphoma Detection

Oxford BioDynamics Demonstrates Use Of EpiSwitch In Lymphoma Detection

23 Dec 2019 06:52

Oxford BioDynamics In Collaboration To Evaluate EpiSwitch Biomarkers

Oxford BioDynamics In Collaboration To Evaluate EpiSwitch Biomarkers

20 Dec 2019 10:43

UK WINNERS & LOSERS SUMMARY: Renewi Jumps 23% As Dutch Eco Ban Lifted

UK WINNERS & LOSERS SUMMARY: Renewi Jumps 23% As Dutch Eco Ban Lifted

11 Dec 2019 17:52

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

11 Dec 2019 16:11

Director dealings: Oxford Biodynamics interim chairman ups stake

(Sharecast News) - Oxford Biodynamics revealed on Wednesday that interim chairman Stephen Diggle had purchased 18,309 ordinary shares in the AIM-listed biotechnology firm.

10 Dec 2019 13:09

Oxford BioDynamics Annual Loss Widens On Increased Costs

Oxford BioDynamics Annual Loss Widens On Increased Costs

25 Oct 2019 11:58

Study Using Oxford BioDynamics' EpiSwitch Enrols First Patient

Study Using Oxford BioDynamics' EpiSwitch Enrols First Patient

28 Aug 2019 17:36

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

(Alliance News) - Oxford BioDynamics PLC said that a company controlled by Non-Executive Director Stephen Diggle bought GBP36,000 worth of shares on Wednesday.Vulpes Life Sciences Fund, by

15 Aug 2019 15:36

DIRECTOR DEALINGS: Oxford BioDynamics Non-Executive Diggle Buys Shares

(Alliance News) - Oxford BioDynamics PLC on Thursday said Non-Executive Director Stephen Diggle acquired shares in the biotechnology company following a transaction on Wednesday.Diggle at a

6 Jun 2019 15:54

DIRECTOR DEALINGS: Non-Exec Linked Fund Buys Oxford BioDynamics Shares

LONDON (Alliance News) - Oxford BioDynamics PLC said Thursday that Vulpes Life Sciences Fund, controlled by Non-Executive Director Steven Diggle, purchased around GBP12,700 in shares in a on fund

31 May 2019 13:01

Long-Serving Oxford Biodynamics Non-Executive Kibble Stands Down

LONDON (Alliance News) - Biotechnology firm Oxford Biodynamics PLC said Friday Non-Executive Director Alison Kibble has stepped down from the firm after 11 years on the board.Kibble - first

28 May 2019 11:50

Oxford BioDynamics Half Year Loss Widens On Increased Costs

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday said its loss widened in the first half of its financial year due to higher staff and administrative costs.Shares in Oxford were a